Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression

被引:48
|
作者
Bi, Ye [1 ]
Shirure, Venktesh S. [2 ]
Liu, Ruiyang [3 ,4 ]
Cunningham, Cassandra [1 ]
Ding, Li [3 ,4 ]
Meacham, J. Mark [5 ]
Goedegebuure, S. Peter [1 ,6 ]
George, Steven C. [2 ]
Fields, Ryan C. [1 ,6 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[3] Washington Univ, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA
[5] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA
[6] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
tumor-on-a-chip; macrophage; angiogenesis; tumor invasion; VON-WILLEBRAND-FACTOR; TISSUE INHIBITOR; CANCER; ANGIOGENESIS; MICROVESSELS; MECHANISMS; EXPRESSION; MODELS;
D O I
10.1093/intbio/zyaa017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor-infiltrating leukocytes, in particular macrophages, play an important role in tumor behavior and clinical outcome. The spectrum of macrophage subtypes ranges from antitumor 'M1'-type to protumor 'M2'-type macrophages. Tumor-associated macrophages (TAMs) typically display phenotypic features of both M1 and M2, and the population distribution is thought to be dynamic and evolves as the tumor progresses. However, our understanding of how TAMs impact the tumor microenvironment remains limited by the lack of appropriate 3D in vitro models that can capture cell-cell dynamics at high spatial and temporal resolution. Using our recently developed microphysiological 'tumor-on-a-chip' (TOC) device, we present here our findings on the impact of defined macrophage subsets on tumor behavior. The TOC device design contains three adjacent and connected chambers in which both the upper and lower chambers are loaded with tumor cells, whereas the central chamber contains a dynamic, perfused, living microvascular network. Introduction of human pancreatic or colorectal cancer cells together with M1-polarized macrophages significantly inhibited tumor growth and tumor-induced angiogenesis. Protein analysis and antibody-based neutralization studies confirmed that these effects were mediated through production of C-X-C motif chemokines (CXCL9), CXCL10 and CXCL11. By contrast, M2-macrophages mediated increased tumor cell migration into the vascularized chamber and did not inhibit tumor growth or angiogenesis. In fact, single-cell RNA sequencing showed that M2 macrophages further segregated endothelial cells into two distinct subsets, corresponding to static cells in vessels versus active cells involved in angiogenesis. The impact of M2 macrophages was mediated mostly by production of matrix metalloproteinase 7 and angiopoietin 2. In summary, our data demonstrate the utility of the TOC device to mechanistically probe biological questions in a 3D in vitro microenvironment.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
  • [21] THE ROLE OF PROLIFERATING MACROPHAGES IN BREAST TUMOR PROGRESSION
    Tonlaar, N. Y.
    Khramtsov, A. I.
    Chen, Y.
    Huo, D.
    Malaka, D. O.
    Oluwasola, O. A.
    Odetunde, A.
    Tretiakova, M. S.
    Li, S.
    Gong, C.
    Tonner, E.
    Falusi, A. G.
    Olopade, O. I.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (03) : 532 - 532
  • [22] Role of Macrophages in Brain Tumor Growth and Progression
    Guadagno, Elia
    Presta, Ivan
    Maisano, Domenico
    Donato, Annalidia
    Pirrone, Caterina Krizia
    Cardillo, Gabriella
    Corrado, Simona Domenica
    Mignogna, Chiara
    Mancuso, Teresa
    Donato, Giuseppe
    De Caro, Marialaura Del Basso
    Malara, Natalia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [23] Elucidating the role of macrophages in tumor development and progression
    Clifford, Adrianne B.
    McGuire, Shannon C.
    Burnett, Sandra H.
    Murray, Byron K.
    O'Neill, Kim L.
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Spatiotemporal dissection of tumor microenvironment via in situ sensing and monitoring in tumor-on-a-chip
    Zhou, Lang
    Liu, Lunan
    Chang, Muammar Ali
    Ma, Chao
    Chen, Weiqiang
    Chen, Pengyu
    BIOSENSORS & BIOELECTRONICS, 2023, 225
  • [25] A Microfluidic Tumor-on-a-Chip for Assessing Multifunctional Liposomes' Tumor Targeting and Anticancer Efficacy
    Ran, Rui
    Wang, Hao-Fei
    Hou, Fei
    Liu, Yun
    Hui, Yue
    Petrovsky, Nikolai
    Zhang, Fan
    Zhao, Chun-Xia
    ADVANCED HEALTHCARE MATERIALS, 2019, 8 (08)
  • [26] Tumor-on-a-chip: from bioinspired design to biomedical application
    Liu, Xingxing
    Fang, Jiaru
    Huang, Shuang
    Wu, Xiaoxue
    Xie, Xi
    Wang, Ji
    Liu, Fanmao
    Zhang, Meng
    Peng, Zhenwei
    Hu, Ning
    MICROSYSTEMS & NANOENGINEERING, 2021, 7 (01)
  • [27] Tumor-On-A-Chip Models for Predicting In Vivo Nanoparticle Behavior
    de Roode, Kim E.
    Hashemi, Khadijeh
    Verdurmen, Wouter P. R.
    Brock, Roland
    SMALL, 2024, 20 (35)
  • [28] The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages
    Tan, Yuying
    Zhao, Lei
    Yang, Yong-Guang
    Liu, Wentao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Using A Bioengineered Immune-enhanced Tumor-on-a-chip (itoc) Platform To Improve T Cell Tumor-killing Capabilities
    Rodriguez, M.
    Kheradmandi, M.
    Sivakumar, H.
    Ilyas, F.
    Beane, J.
    Skardal, A.
    TISSUE ENGINEERING PART A, 2022, 28 : 31 - 32
  • [30] 3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
    Samadian, H.
    Jafari, S.
    Sepand, M. R.
    Alaei, L.
    Malvajerd, S. Sadegh
    Jaymand, M.
    Ghobadinezhad, F.
    Jahanshahi, F.
    Hamblin, M. R.
    Derakhshankhah, H.
    Izadi, Z.
    MATERIALS TODAY ADVANCES, 2021, 12